113 related articles for article (PubMed ID: 20055748)
21. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
22. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
[TBL] [Abstract][Full Text] [Related]
23. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
24. Duration of corneal anaesthesia following multiple doses and two concentrations of tetracaine hydrochloride eyedrops on the normal equine cornea.
Monclin SJ; Farnir F; Grauwels M
Equine Vet J; 2011 Jan; 43(1):69-73. PubMed ID: 21143636
[TBL] [Abstract][Full Text] [Related]
25. Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.
Pastor E; Matveeva E; Valle-Gallego A; Goycoolea FM; Garcia-Fuentes M
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):601-9. PubMed ID: 21855304
[TBL] [Abstract][Full Text] [Related]
26. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
27. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
28. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
Wang LY; Ma GH; Su ZG
J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
[TBL] [Abstract][Full Text] [Related]
29. Drug-polymer microparticles produced by supercritical assisted atomization.
Reverchon E; Antonacci A
Biotechnol Bioeng; 2007 Aug; 97(6):1626-37. PubMed ID: 17286274
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
Xie J; Wang CH
Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
[TBL] [Abstract][Full Text] [Related]
31. Incorporation of a model protein into chitosan-bile salt microparticles.
Lameiro MH; Lopes A; Martins LO; Alves PM; Melo E
Int J Pharm; 2006 Apr; 312(1-2):119-30. PubMed ID: 16480840
[TBL] [Abstract][Full Text] [Related]
32. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin.
Zheng CH; Liang WQ; Li F; Zhang YP; Fang WJ
Pharmazie; 2005 Jun; 60(6):434-8. PubMed ID: 15997832
[TBL] [Abstract][Full Text] [Related]
33. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
[TBL] [Abstract][Full Text] [Related]
34. Effect of levofloxacin and pefloxacin on humoral immune response elicited by bovine serum albumin docked in gelatin microparticles and nanoparticles.
Madan J; Kaushik D; Sardana S; Ali A; Sudhakaran Sudheesh M; Shankar Pandey R
Pharmazie; 2010 Apr; 65(4):284-9. PubMed ID: 20432626
[TBL] [Abstract][Full Text] [Related]
35. Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone.
Pavanetto F; Genta I; Giunchedi P; Conti B; Conte U
J Microencapsul; 1994; 11(4):445-54. PubMed ID: 7931944
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
38. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
Li N; Zhuang C; Wang M; Sun X; Nie S; Pan W
Int J Pharm; 2009 Sep; 379(1):131-8. PubMed ID: 19559775
[TBL] [Abstract][Full Text] [Related]
39. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
40. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
